|
US3117142A
(en)
|
1961-03-01 |
1964-01-07 |
Roussel Uclaf |
Novel preparation of estradiol and estrone
|
|
US3169134A
(en)
|
1963-03-21 |
1965-02-09 |
Searle & Co |
2, 3-oxygenated-17alpha-methyl-5alpha-androstan-17beta-ols
|
|
BE754111A
(fr)
|
1969-07-29 |
1971-01-29 |
Upjohn Co |
Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation
|
|
US3943124A
(en)
|
1970-12-17 |
1976-03-09 |
Gordon Hanley Phillipps |
Chemical compounds
|
|
US3983111A
(en)
|
1972-05-05 |
1976-09-28 |
Glaxo Laboratories Limited |
Steroidal anaesthetics of the pregnane and 19-norpregnane series
|
|
GB1430942A
(en)
|
1972-05-05 |
1976-04-07 |
Glaxo Lab Ltd |
21-substituted 3alpha-hydroxy pregnanes
|
|
US3865939A
(en)
|
1973-02-23 |
1975-02-11 |
Procter & Gamble |
Edible oils having hypocholesterolemic properties
|
|
US4071625A
(en)
|
1974-05-13 |
1978-01-31 |
Richardson-Merrell Inc. |
19-Oxygenated-5α-androstanes for the enhancement of libido
|
|
US4192871A
(en)
|
1976-01-06 |
1980-03-11 |
Glaxo Laboratories Limited |
Chemical compounds
|
|
GB1570394A
(en)
|
1976-01-06 |
1980-07-02 |
Glaxo Lab Ltd |
11-acyloxy-3-hydroxy steroids
|
|
GB1581234A
(en)
|
1976-04-05 |
1980-12-10 |
Glaxo Operations Ltd |
11a - amino - 3a - hydroxysteroids
|
|
US5847009A
(en)
|
1986-01-14 |
1998-12-08 |
Alliance Pharmaceutical Corp. |
Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
|
|
SE8600632D0
(sv)
|
1986-02-13 |
1986-02-13 |
Kabivitrum Ab |
Novel pharmaceutical composition
|
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
|
US5120723A
(en)
|
1987-08-25 |
1992-06-09 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5319115A
(en)
|
1987-08-25 |
1994-06-07 |
Cocensys Inc. |
Method for making 3α-hydroxy, 3β-substituted-pregnanes
|
|
US5719197A
(en)
*
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
MY107937A
(en)
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
|
EP0603312A4
(en)
|
1991-09-13 |
1995-06-07 |
Cocensys Inc |
NEW GABA A RECEPTOR WITH STEROID BINDING POINTS.
|
|
DE69435286D1
(de)
|
1993-05-24 |
2010-05-20 |
Purdue Pharma Ltd |
Verfahren und zusammensetzungen zum hervorrufen von schlaf
|
|
EP0656365B1
(en)
|
1993-12-02 |
1997-04-09 |
Akzo Nobel N.V. |
Substituted 2beta-morpholinoandrostane derivatives
|
|
US5939545A
(en)
|
1994-02-14 |
1999-08-17 |
Cocensys, Inc. |
Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
|
|
ES2296594T3
(es)
|
1994-02-14 |
2008-05-01 |
Euro-Celtique S.A. |
Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
AU3125695A
(en)
|
1994-07-21 |
1996-02-22 |
Pharmacia & Upjohn Company |
Neurologically active aminosteroids
|
|
NZ298567A
(en)
|
1994-11-23 |
2000-01-28 |
Cocensys Inc |
Androstane and pregnane derivatives, pharmaceutical compositions and methods of treatment
|
|
US6780853B1
(en)
*
|
1995-06-06 |
2004-08-24 |
Euro-Celtique S.A. |
Neuroactive steroids of the androstane and pregnane series
|
|
ATE284895T1
(de)
|
1995-06-06 |
2005-01-15 |
Euro Celtique Sa |
Neuroaktive steroide der androstan- und pregnanreihe
|
|
EP0840612A1
(en)
|
1995-07-24 |
1998-05-13 |
Trustees Of Boston University |
Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
|
|
WO1998005337A1
(en)
|
1996-08-01 |
1998-02-12 |
Cocensys, Inc. |
Use of gaba and nmda receptor ligands for the treatment of migraine headache
|
|
PT839525E
(pt)
|
1996-10-31 |
2004-10-29 |
Takeda Chemical Industries Ltd |
Preparacao de libertacao prolongada
|
|
US7630757B2
(en)
*
|
1997-01-06 |
2009-12-08 |
Flint Hills Scientific Llc |
System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
US6316613B1
(en)
|
1997-07-25 |
2001-11-13 |
Beckman Coulter, Inc. |
Chiral separation of pharmaceutical compounds with charged cyclodextrins using capillary electrophoresis
|
|
US6245757B1
(en)
|
1997-10-03 |
2001-06-12 |
Research Corporation Technologies, Inc. |
Use of progestins to treat ischemic event
|
|
AU756001B2
(en)
|
1998-03-11 |
2003-01-02 |
Umecrine Mood Ab |
Epiallopregnanolone in the treatment of CNS disorders
|
|
US20020198174A1
(en)
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
|
US6376531B1
(en)
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
|
US20030236236A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
PT1104760E
(pt)
|
1999-12-03 |
2003-06-30 |
Pfizer Prod Inc |
Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios
|
|
US6442887B2
(en)
|
2000-02-25 |
2002-09-03 |
Robert L. Sanquist |
Live bait keeper
|
|
IN187686B
(https=)
|
2000-06-21 |
2002-06-08 |
Bharat Serums & Vaccines Ltd |
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US20020072509A1
(en)
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
|
GR1003861B
(el)
*
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
|
EP1360310A2
(en)
|
2001-02-13 |
2003-11-12 |
University Of Florida |
A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
US20030032638A1
(en)
|
2001-05-24 |
2003-02-13 |
Kim John J. |
Delivery of benzodiazepines through an inhalation route
|
|
ATE415155T1
(de)
|
2001-05-24 |
2008-12-15 |
Alexza Pharmaceuticals Inc |
Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
JP2003063965A
(ja)
|
2001-06-13 |
2003-03-05 |
Otsuka Pharmaceut Factory Inc |
注射用シロスタゾール水性製剤
|
|
JP2005519294A
(ja)
|
2002-01-14 |
2005-06-30 |
アンセル・ヘルスケア・プロダクツ・インコーポレーテッド |
磁気検出可能ラテックス物品
|
|
US7550155B2
(en)
|
2002-07-29 |
2009-06-23 |
Transform Pharmaceuticals Inc. |
Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
|
|
EP2298315A1
(en)
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Therapeutic treatment methods
|
|
US9339508B2
(en)
|
2003-01-17 |
2016-05-17 |
Mapreg |
Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury
|
|
WO2005000869A1
(en)
|
2003-05-29 |
2005-01-06 |
Washington University |
Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally-related pentacyclic steroids
|
|
US7816074B2
(en)
*
|
2003-07-31 |
2010-10-19 |
The Research Foundation Of State University Of New York |
α4 β2 δGABA-A receptors as a strategy for PMS and alcoholism
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
|
DE602005026225D1
(de)
|
2004-03-12 |
2011-03-24 |
Cipla Ltd |
Sterilisationsprozess für Steroide
|
|
WO2005105822A2
(en)
|
2004-04-23 |
2005-11-10 |
Euro-Celtique S.A. |
3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof
|
|
ITMI20041763A1
(it)
|
2004-09-16 |
2004-12-16 |
Altergon Sa |
Nuove formulazioni iniettabili contenenti progesterone
|
|
US20060063707A1
(en)
|
2004-09-17 |
2006-03-23 |
Lifelike Biomatic, Inc. |
Compositions for enhancing memory and methods therefor
|
|
US8604011B2
(en)
|
2004-09-27 |
2013-12-10 |
The Regents Of The University Of California |
Therapy for treatment of chronic degenerative brain diseases and nervous system injury
|
|
US8557861B2
(en)
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
EP2471536A1
(en)
|
2004-09-29 |
2012-07-04 |
Harbor BioSciences, Inc. |
Steroid analogs and characterization and treatment methods
|
|
KR20070112164A
(ko)
|
2005-02-15 |
2007-11-22 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 벤조디아제핀의 에어로졸과 주사가능한 제제
|
|
DE602006020353D1
(de)
*
|
2005-03-24 |
2011-04-07 |
Univ Emory |
Progesterone Dosierungsanweisung in der Behandlung einer traumatischen Verletzung des Gehirns
|
|
JP2008538748A
(ja)
*
|
2005-04-07 |
2008-11-06 |
ハイシアム， インコーポレイテッド |
不安、物質乱用及び依存の予防のための改良型方法及び組成物
|
|
US20110319386A1
(en)
|
2005-08-26 |
2011-12-29 |
Braincells Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
US7858609B2
(en)
|
2005-11-28 |
2010-12-28 |
Marinus Pharmaceuticals |
Solid ganaxolone formulations and methods for the making and use thereof
|
|
CA2632395A1
(en)
*
|
2005-12-05 |
2007-06-14 |
Neurosearch A/S |
Benzimidazole derivatives and their use for modulating the gabaa receptor complex
|
|
US20070155824A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
US20070287931A1
(en)
|
2006-02-14 |
2007-12-13 |
Dilorenzo Daniel J |
Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
|
|
EP1873527A1
(en)
*
|
2006-06-30 |
2008-01-02 |
Schwarz Pharma Ag |
Method for identifying CRMP modulators
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20090239942A1
(en)
*
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
|
US20090074677A1
(en)
|
2007-01-08 |
2009-03-19 |
Duke University |
Neuroactive steroid compositions and methods of use therefor
|
|
US20090203658A1
(en)
|
2007-01-08 |
2009-08-13 |
Duke University |
Neuroactive steroid compositions and methods of use therefor
|
|
US7813811B2
(en)
|
2007-02-08 |
2010-10-12 |
Neuropace, Inc. |
Refillable reservoir lead systems
|
|
LT2545939T
(lt)
|
2007-04-11 |
2021-03-10 |
Biomarin Pharmaceutical Inc. |
Tetrahidrobiopterinas, skirtas gydyti ligas, susijusias supadidėjusiu fenilalanino kiekiu
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
EP2167098B1
(en)
|
2007-06-11 |
2018-09-05 |
University Of Southern California |
Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
|
|
CA2698172C
(en)
|
2007-06-15 |
2014-02-18 |
Cook, Kevin M. |
Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
|
|
GB0711948D0
(en)
|
2007-06-20 |
2007-08-01 |
Bionature E A Ltd |
Neurosteriod compounds
|
|
WO2009000038A1
(en)
|
2007-06-28 |
2008-12-31 |
Cnsbio Pty Ltd |
Combination methods and compositions for treatment of neuropathic pain
|
|
CN106038481A
(zh)
*
|
2007-06-28 |
2016-10-26 |
锡德克斯药物公司 |
皮质类固醇水溶液的鼻部和眼部给药
|
|
JP2011507800A
(ja)
|
2007-12-26 |
2011-03-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
癲癇、精神障害、または感覚器官の障害のためのａｍｐａ受容体アンタゴニスト
|
|
RU2470642C2
(ru)
|
2008-01-03 |
2012-12-27 |
Байомарин Фармасьютикл Инк. |
Аналоги птерина для лечения состояния, чувствительного к вн4
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
US8729070B2
(en)
|
2008-02-20 |
2014-05-20 |
Targia Pharmaceuticals |
CNS pharmaceutical compositions and methods of use
|
|
DE102008015366A1
(de)
|
2008-03-20 |
2009-09-24 |
Merck Patent Gmbh |
Lyophilisierte Nanoemulsion
|
|
CZ2008434A3
(cs)
|
2008-07-10 |
2009-12-09 |
Ústav organické chemie a biochemie Akademie ved CR, v. v. i. |
Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
|
|
WO2010014913A1
(en)
*
|
2008-08-01 |
2010-02-04 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
|
WO2010042925A2
(en)
*
|
2008-10-10 |
2010-04-15 |
Vm Discovery Inc. |
Compositions and methods for treating alcohol use disorders, pain and other diseases
|
|
EP2376073A2
(en)
*
|
2008-11-30 |
2011-10-19 |
Oron Zachar |
Dermal application of vasoconstrictors
|
|
US20110306579A1
(en)
*
|
2009-01-30 |
2011-12-15 |
Emory University |
Methods of neuroprotection using neuroprotective steroids and a vitamin d
|
|
US20120142645A1
(en)
|
2009-03-17 |
2012-06-07 |
Marx Christine E |
Neuroactive steroid compositions and methods of use for lowering cholesterol
|
|
US20110152840A1
(en)
|
2009-12-23 |
2011-06-23 |
Drugtech Corporation |
Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
|
|
SMT201700518T1
(it)
|
2010-01-21 |
2018-01-11 |
Drawbridge Pharmaceuticals Pty Ltd |
Formulazione anestetica
|
|
WO2012059456A1
(en)
*
|
2010-11-03 |
2012-05-10 |
Sanofi-Aventis Deutschland Gmbh |
Needle cannula containing medicament
|
|
WO2012075286A2
(en)
*
|
2010-12-01 |
2012-06-07 |
The Regents Of The University Of California |
Intrapulmonary benzodiazepine for the treatment and prevention of seizures
|
|
CZ201181A3
(cs)
|
2011-02-15 |
2012-09-12 |
Ústav organické chemie a biochemie Akademie ved CR, v.v.i. |
Deriváty pregnanolonu substituované v poloze 3alfa kationickou skupinou, zpusob jejich výroby, jejich použití a prostredek je obsahující
|
|
US9388210B2
(en)
|
2011-02-25 |
2016-07-12 |
Washington University |
Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
|
|
FR2973031B1
(fr)
|
2011-03-23 |
2013-11-29 |
Univ Strasbourg |
Derives de l'allopregnanolone et de l'epiallopregnanolone et leurs utilisations pour traiter un etat neuropathologique
|
|
US9084797B2
(en)
|
2011-05-23 |
2015-07-21 |
Besins Healthcare Luxembourg Sarl |
Progesterone treatment for improving sleep quality
|
|
JP5893135B2
(ja)
|
2011-06-28 |
2016-03-23 |
ビボゾーン インコーポレイテッド |
多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途
|
|
JP2014521662A
(ja)
|
2011-07-29 |
2014-08-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ＧＡＢＡＡ受容体のモジュレーターとしての新規な１７β−ヘテロアリール置換ステロイド
|
|
CA2848212C
(en)
|
2011-09-08 |
2022-03-29 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
WO2013043985A1
(en)
|
2011-09-23 |
2013-03-28 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
EP3572417B1
(en)
|
2011-10-14 |
2025-12-17 |
Sage Therapeutics, LLC |
3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
|
|
US9125926B2
(en)
|
2011-11-29 |
2015-09-08 |
Amino Up Chemical Co. Ltd |
Vicenin 2 and analogues thereof for use as an antispasmodic and/or prokinetic agent
|
|
EP2806877B2
(en)
|
2012-01-23 |
2025-01-29 |
Sage Therapeutics, Inc. |
Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
|
|
US20150175651A1
(en)
|
2012-06-15 |
2015-06-25 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
US20140050789A1
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
CA2882708A1
(en)
|
2012-08-21 |
2014-02-27 |
Sage Therapeutics, Inc. |
Methods of treating epilepsy or status epilepticus
|
|
WO2014058736A1
(en)
|
2012-10-08 |
2014-04-17 |
Washington University |
Neuroactive 19-alkoxy-17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
|
|
ES3056529T3
(en)
|
2012-11-09 |
2026-02-23 |
Drawbridge Pharmaceuticals Pty Ltd |
Neuroactive steroids and their use to facilitate neuroprotection
|
|
AU2013352141B2
(en)
|
2012-11-30 |
2018-04-05 |
The Regents Of The University Of California |
Anticonvulsant activity of steroids
|
|
HUE039057T2
(hu)
|
2012-12-18 |
2018-12-28 |
Univ Washington |
Kezelési eljárásokban alkalmazható neuroaktív 19-alkoxi-17-szubsztituált szteroidok
|
|
WO2014108808A2
(en)
|
2013-01-09 |
2014-07-17 |
Henry James Lorne |
Pharmaceutical formulations for the treatment and prevention of trauma-induced neuropathology and neurodegeneration
|
|
EP2986624B1
(en)
|
2013-04-17 |
2020-03-25 |
Sage Therapeutics, Inc. |
19-nor neuroactive steroids for methods of treatment
|
|
US20160068563A1
(en)
|
2013-04-17 |
2016-03-10 |
Boyd L. Harrison |
19-nor neuroactive steroids and methods of use thereof
|
|
US9725481B2
(en)
|
2013-04-17 |
2017-08-08 |
Sage Therapeutics, Inc. |
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
|
|
KR102396328B1
(ko)
|
2013-04-17 |
2022-05-10 |
세이지 테라퓨틱스, 인크. |
19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
|
|
SI3021852T1
(sl)
|
2013-07-19 |
2021-07-30 |
Sage Therapeutics, Inc. |
Nevroaktivni steroidi, sestavki in uporabe le-teh
|
|
AU2014308621C1
(en)
|
2013-08-23 |
2022-01-06 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
ES2805598T3
(es)
|
2014-05-29 |
2021-02-12 |
Sage Therapeutics Inc |
Esteroides neuroactivos, composiciones y usos de los mismos
|
|
US10246482B2
(en)
|
2014-06-18 |
2019-04-02 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
ME03809B
(me)
|
2014-10-16 |
2021-04-20 |
Sage Therapeutics Inc |
KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
|
|
CN117024501A
(zh)
|
2014-10-16 |
2023-11-10 |
萨奇治疗股份有限公司 |
靶向cns障碍的组合物和方法
|
|
WO2016082789A1
(en)
|
2014-11-27 |
2016-06-02 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
RS61530B1
(sr)
|
2015-01-26 |
2021-04-29 |
Sage Therapeutics Inc |
Kompozicije i postupci za lečenje poremećaja cns
|
|
CA2973140C
(en)
|
2015-02-06 |
2025-09-16 |
Marinus Pharmaceuticals, Inc. |
Intravenous Ganaxolone Formulations and Their Use in the Treatment of Status Epilepticus and Other Epileptic Disorders
|
|
EP4155314A1
(en)
|
2015-02-20 |
2023-03-29 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
EP3280420B1
(en)
|
2015-04-10 |
2024-03-27 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
AR105044A1
(es)
|
2015-06-18 |
2017-08-30 |
Sage Therapeutics Inc |
Soluciones de esteroides neuroactivos y sus métodos de uso, recipiente
|
|
GB2541015A
(en)
|
2015-08-06 |
2017-02-08 |
Ge Oil & Gas Uk Ltd |
Subsea flying lead
|
|
JP6957455B2
(ja)
|
2015-10-14 |
2021-11-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
ベータ細胞の複製及び／または生存の亢進
|
|
MA43284A
(fr)
|
2015-11-20 |
2018-09-26 |
Sage Therapeutics Inc |
Composés et leurs méthodes d'utilisation
|
|
KR20240157128A
(ko)
|
2016-03-08 |
2024-10-31 |
세이지 테라퓨틱스, 인크. |
신경활성 스테로이드, 조성물, 및 그의 용도
|
|
WO2018013615A1
(en)
|
2016-07-11 |
2018-01-18 |
Sage Therapeutics, Inc. |
C7, c12, and c16 substituted neuroactive steroids and their methods of use
|
|
MA45599A
(fr)
|
2016-07-11 |
2019-05-15 |
Sage Therapeutics Inc |
Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
|
|
EP3481387A4
(en)
|
2016-08-11 |
2020-04-08 |
Ovid Therapeutics Inc |
METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES
|
|
US20180050107A1
(en)
|
2016-08-16 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Neurosteroid compositions and methods of use thereof
|
|
US20180050005A1
(en)
|
2016-08-16 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Concentrated Solution of 17-Hydroxydocosahexaenoic Acid
|
|
EP3504189A1
(en)
|
2016-08-23 |
2019-07-03 |
Sage Therapeutics, Inc. |
A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid
|
|
US10098895B2
(en)
|
2016-09-07 |
2018-10-16 |
Glia, Llc |
Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves
|
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
|
WO2018169798A1
(en)
|
2017-03-11 |
2018-09-20 |
The Regents Of The University Of California |
Mitigation of cns disorders by combination therapy using neurosteroids, and ampa blockers
|
|
EP3612186A1
(en)
|
2017-04-18 |
2020-02-26 |
Marinus Pharmaceuticals, Inc. |
Sustained release injectable neurosteroid formulations
|
|
US20180338959A1
(en)
|
2017-05-24 |
2018-11-29 |
Ovid Therapeutics Inc. |
Treatment of depressive disorders
|
|
US11752115B2
(en)
|
2017-06-21 |
2023-09-12 |
The Board Of Trustees Of The University Of Illinois |
PPAR-alpha agonist treatment of neuropsychiatric disorders
|
|
US11992495B2
(en)
|
2017-06-23 |
2024-05-28 |
The Regents Of The University Of California |
Enhancing GABA's ability to modulate immune responses
|
|
CA3068462A1
(en)
|
2017-06-23 |
2019-12-27 |
The Board Of Trustees Of The University Of Illinois |
Treatment of neuropsychiatric disorders with neurosteroids and analogues thereof
|
|
WO2019051264A1
(en)
|
2017-09-07 |
2019-03-14 |
Sage Therapeutics, Inc. |
NEUROACTIVE STEROIDS AND METHODS OF USE
|
|
US20200276209A1
(en)
|
2017-09-11 |
2020-09-03 |
Sage Therapeutics, Inc. |
Methods of treating epilepsy or status epilepticus
|
|
CA3075872A1
(en)
|
2017-09-14 |
2019-03-21 |
Sage Therapeutics, Inc. |
A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof
|
|
MY204493A
(en)
|
2017-11-10 |
2024-08-30 |
Marinus Pharmaceuticals Inc |
Ganaxolone for use in treating genetic epileptic disorders
|
|
MA51046A
(fr)
|
2017-12-08 |
2021-03-17 |
Sage Therapeutics Inc |
Dérivés de 21-[4-cyano-pyrazol-1-yl]-19-nor-pregan-3. alpha-ol-20-one deutérés pour le traitement de troubles du snc
|
|
MX2020006599A
(es)
|
2017-12-22 |
2020-11-06 |
Sage Therapeutics Inc |
Composiciones y metodos para el tratamiento de trastornos en el sistema nervioso central.
|
|
BR112020012761A2
(pt)
|
2017-12-22 |
2021-02-17 |
Sage Therapeutics, Inc. |
composições e métodos para o tratamento de distúrbios do snc
|
|
TW201930269A
(zh)
|
2018-01-12 |
2019-08-01 |
美商賽吉醫療公司 |
用於治療cns病症之組合物及方法
|
|
AR116659A1
(es)
|
2018-05-04 |
2021-06-02 |
Acerus Pharmaceuticals Corp |
Derivados de neuroesteroides y usos de estos
|
|
CA3103421A1
(en)
|
2018-06-12 |
2019-12-19 |
Sage Therapeutics, Inc. |
A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof
|
|
EP4321519B1
(en)
|
2018-10-12 |
2026-04-08 |
Sage Therapeutics, LLC |
Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders
|
|
ES3039267T3
(en)
|
2018-10-19 |
2025-10-20 |
Sage Therapeutics Inc |
9(11)-unsaturated neuroactive steroids and their methods of use
|
|
US11311529B2
(en)
|
2018-11-08 |
2022-04-26 |
Varsona Therapeutics, Inc. |
Topical formulations of 5-α-reductase inhibitors and uses thereof
|
|
JP2022514194A
(ja)
|
2018-11-21 |
2022-02-10 |
セルテゴ セラピューティクス インコーポレイテッド |
自殺のリスクを低減し、うつ病を迅速に軽減するためのガボキサドール
|
|
KR20250174100A
(ko)
|
2018-12-05 |
2025-12-11 |
세이지 테라퓨틱스, 인크. |
신경활성 스테로이드 및 이의 사용 방법
|
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
|
CN113365635A
(zh)
|
2018-12-14 |
2021-09-07 |
阿克罗斯生物制药公司 |
睾酮的活性酯衍生物、组合物和其用途
|
|
WO2020132504A1
(en)
|
2018-12-21 |
2020-06-25 |
Sage Therapeutics, Inc. |
3.alpha.-hydroxy-17.beta.-amide neuroactive steroids and compositions thereof
|
|
TW202523658A
(zh)
|
2019-05-24 |
2025-06-16 |
美商賽吉醫療公司 |
化合物、組合物及使用方法
|
|
SG11202112391UA
(en)
|
2019-05-31 |
2021-12-30 |
Sage Therapeutics Inc |
Neuroactive steroids and compositions thereof
|
|
CN114729000A
(zh)
|
2019-06-27 |
2022-07-08 |
萨奇治疗股份有限公司 |
用于治疗cns病症的化合物
|
|
CA3143509A1
(en)
|
2019-06-27 |
2020-12-30 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
JP7754725B2
(ja)
|
2019-06-27 |
2025-10-15 |
セージ セラピューティクス， インコーポレイテッド |
Ｃｎｓ障害を治療するための組成物及び方法
|
|
KR20220112803A
(ko)
|
2019-12-05 |
2022-08-11 |
세이지 테라퓨틱스, 인크. |
19-nor c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
|
|
WO2021188778A2
(en)
|
2020-03-18 |
2021-09-23 |
Sage Therapeutics, Inc. |
Neuroactive steroids and their methods of use
|
|
EP4125921A1
(en)
|
2020-03-25 |
2023-02-08 |
Sage Therapeutics, Inc. |
Use of agents for treatment of respiratory conditions
|
|
US20230250129A1
(en)
|
2020-06-24 |
2023-08-10 |
Sage Therapeutics, Inc. |
Neuroactive steroids and compositions thereof
|
|
KR20230041049A
(ko)
|
2020-07-20 |
2023-03-23 |
세이지 테라퓨틱스, 인크. |
19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드의 제형 및 이의 사용 방법
|
|
WO2022115381A1
(en)
|
2020-11-25 |
2022-06-02 |
Sage Therapeutics, Onc. |
Compositions and methods for treating cns disorders cross reference to related application
|
|
KR20230136599A
(ko)
|
2021-01-28 |
2023-09-26 |
세이지 테라퓨틱스, 인크. |
성 기능장애의 치료를 위한 신경활성 스테로이드의용도
|
|
WO2022177718A1
(en)
|
2021-02-18 |
2022-08-25 |
Sage Therapeutics, Inc. |
Use of neuroactive steroid for treatment of sexual dysfunction
|
|
US20240245711A1
(en)
|
2021-03-17 |
2024-07-25 |
Sage Therapeutics, Inc. |
A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for the treatment of major depressive disorder
|
|
JP2024513581A
(ja)
|
2021-04-12 |
2024-03-26 |
セージ セラピューティクス， インコーポレイテッド |
本態性振戦の治療
|
|
EP4329769A1
(en)
|
2021-04-29 |
2024-03-06 |
Sage Therapeutics, Inc. |
Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female
|
|
WO2022232504A1
(en)
|
2021-04-29 |
2022-11-03 |
Sage Therapeutics, Inc. |
19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid for use in treating major depressive disorder and postpartum depression
|
|
IL315023A
(en)
|
2022-02-16 |
2024-10-01 |
Sage Therapeutics Inc |
Neuroactive steroids for treatment of cns-related disorders
|
|
WO2023163879A1
(en)
|
2022-02-28 |
2023-08-31 |
Sage Therapeutics, Inc. |
Neuroactive steroids for treatment of gastrointestinal diseases or conditions
|